United States · FDA National Drug Code directory
Repaglinide
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 63629-4866_3511b6fb-ead0-43db-ba3e-15dff208f04b
- Product NDC
- 63629-4866
- Form
- TABLET
- Composition / generic term
- Repaglinide
- Labeler
- Bryant Ranch Prepack
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20140122
- Source listing expiry
- 20261231
Source-listed ingredients
- REPAGLINIDE — .5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET in 1 BOTTLE (63629-4866-1) · 63629-4866-1
- 90 TABLET in 1 BOTTLE (63629-4866-2) · 63629-4866-2
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →